Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CRHBP | P24387 | 2/20 | 0.52 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.49 |
| ▸ | GRM5 | P41594 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12124662 | 0.88 | CYP1A2 (0.54) | ALDH1A1CYP1A2CYP2C9CYP2C19MAPT | |
| SCHEMBL14334518 | 0.82 | ALDH1A1 (0.68) | ALDH1A1CYP1A2CYP2C9CYP2C19MAPT | |
| SCHEMBL3281579 | 0.81 | ALDH1A1 (0.66) | ALDH1A1CYP1A2CYP2C9CYP2C19MAPT | |
| SCHEMBL3281568 | 0.81 | ALDH1A1 (0.66) | ALDH1A1CYP1A2CYP2C9CYP2C19MAPT | |
| SCHEMBL29445475 | 0.80 | CYP1A2 (0.71) | ALDH1A1CYP1A2CYP2C9CYP2C19MAPT | |
| SCHEMBL14377392 | 0.80 | CYP1A2 (0.71) | ALDH1A1CYP1A2CYP2C9CYP2C19MAPT | |
| SCHEMBL8259130 | 0.80 | CYP1A2 (0.71) | ALDH1A1CYP1A2CYP2C9CYP2C19MAPT | |
| SCHEMBL3436165 | 0.80 | ALDH1A1 (0.74) | ALDH1A1CYP1A2CYP2C9CYP2C19MAPT | |
| SCHEMBL12639914 | 0.78 | ALDH1A1 (0.72) | ALDH1A1CYP1A2CYP2C9CYP2C19MAPT | |
| SCHEMBL781659 | 0.78 | CYP1A2 (0.87) | ALDH1A1CYP1A2CYP2C9CYP2C19MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8058292-B2 | Therapeutic agents useful for treating pain | PURDUE PHARMA L.P. (US) | 2011-11-15 | — | — | US | disclosed |
| US-20100256111-A1 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | PURDUE PHARMA L.P. (US) | 2010-10-07 | — | — | US | disclosed |
| US-7767699-B2 | Therapeutic agents useful for treating pain | PURDUE PHARMA, L.P. (US) | 2010-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256111-A1 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | CHRNA10, ACHE, SNCA | ALDH1A1 453/4885CYP1A2 2596/4885CYP2C9 2716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.